Please complete this form and list your purchase and sale transaction(s) for Health Insurance Innovations, Inc. (Nasdaq: HIIQ) securities between August 4, 2017 and September 11, 2017, both dates inclusive (the “Class Period”):
You may also contact Jon Naji, Esq. (484) 270-1453; or you may submit your information via email at email@example.com, or you may click here to print a PDF of this form.
On September 21, 2017, the initial complaint in this securities class action was filed against Health Insurance Innovations, Inc. (“Health Insurance”), and certain of Health Insurance’s directors and officers, asserting violations of sections 10(b) and 20(a) of the Securities Exchange Act.
Lead Plaintiff alleges defendants made misleading statements to investors in their August 2017 10-Q. Their alleged material misrepresentations and omissions injured each Class member who acquired HIIQ securities during the Class Period. Common questions of law or fact include whether: (i) Defendants violated the Exchange Act; (ii) Defendants omitted and/or misrepresented material facts; (iii) Defendants knew or recklessly disregarded that their statements were false and misleading; (iv) the price of HIIQ securities was artificially inflated during the class period; as well as (v) the extent and appropriate measure of damage sustained by Class members.
This securities class action lawsuit was brought on behalf of all persons or entities who purchased or otherwise acquired HIIQ Class A Common Stock (trading symbol HIIQ) or exchange-traded Call Options on HIIQ Class A Common Stock, and all persons who sold (wrote) exchange-traded Put Options on HIIQ Class A Common Stock, between August 4, 2017 and September 11, 2017, inclusive.
Current Status of Case:
The Parties engaged in a mediation session on April 30, 2020 whereby they reached an agreement in principle to settle the case for $2,800,000. On June 22, 2020, Lead Plaintiff filed his Motion for Settlement Preliminary Approval. On March 30, 2021 the Court approved the settlement and on July 2, 2021 a Final Judgement and Dismissal was entered.
Case has concluded.
If you wish to discuss this action or have any questions concerning this notice or your rights or interests with respect to these matters, please contact Kessler Topaz Meltzer & Check, LLP: Jon Naji, Esq. (484) 270-1453; via e-mail at firstname.lastname@example.org. If you would like additional information about the suit, please click on the link "Submit Your Information" above and fill out the form as promptly as possible.